News NICE in drive to increase paediatric vaccinations Draft quality standard is response to low uptake.
News Novartis move damages CAR-T confidence Swiss pharma axes gene therapy unit, causing investor angst.
Views & Analysis Digital Health Round-up – DeepMind & UCLH; Google Glass A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis England’s ‘world-first’ cancer database – can it deliver on ... The world's first national database of cancer treatment outcomes has been launched in England.
News Novartis' Arzerra gains CLL approval Development partner Genmab says drug approved in relapsed disease.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.